TR200201167T2 - Sodyum-hidrojen değiştirici tip 1 önleyici kristalleri. - Google Patents

Sodyum-hidrojen değiştirici tip 1 önleyici kristalleri.

Info

Publication number
TR200201167T2
TR200201167T2 TR2002/01167T TR200201167T TR200201167T2 TR 200201167 T2 TR200201167 T2 TR 200201167T2 TR 2002/01167 T TR2002/01167 T TR 2002/01167T TR 200201167 T TR200201167 T TR 200201167T TR 200201167 T2 TR200201167 T2 TR 200201167T2
Authority
TR
Turkey
Prior art keywords
sodium
inhibitor crystals
crystals
inhibitor
exchanger type
Prior art date
Application number
TR2002/01167T
Other languages
English (en)
Inventor
Robinson Brostrom Lyle
Joseph Connolly Terrence
Jane Li Zheng
Lee Orrill Susan
Kiritkumar Shah Bharat
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of TR200201167T2 publication Critical patent/TR200201167T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Surgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Treatment Of Water By Ion Exchange (AREA)

Abstract

NHE-1 önleyici kristalleri, bu gibi NHE-1 önleyici kristallerinin kullanim yöntemleri ve bu gibi NHE-1 önleyici kristallerini içeren farmasötik bilesimler. NHE-1 önleyici kristalleri doku isemisi yani dokunun bölgesel olarak kansiz kalmasi sonucu ortaya çikan doku hasarinin azaltilmasi için yararlidirlar.
TR2002/01167T 1999-10-29 2000-10-09 Sodyum-hidrojen değiştirici tip 1 önleyici kristalleri. TR200201167T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16237499P 1999-10-29 1999-10-29

Publications (1)

Publication Number Publication Date
TR200201167T2 true TR200201167T2 (tr) 2002-08-21

Family

ID=22585355

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/01167T TR200201167T2 (tr) 1999-10-29 2000-10-09 Sodyum-hidrojen değiştirici tip 1 önleyici kristalleri.

Country Status (44)

Country Link
EP (1) EP1224179B1 (tr)
JP (1) JP2003512455A (tr)
KR (1) KR100464526B1 (tr)
CN (2) CN1205205C (tr)
AP (1) AP2002002493A0 (tr)
AR (1) AR029402A1 (tr)
AT (1) ATE271047T1 (tr)
AU (1) AU778573B2 (tr)
BG (1) BG106729A (tr)
BR (1) BR0015275A (tr)
CA (1) CA2389020A1 (tr)
CO (1) CO5271714A1 (tr)
CZ (1) CZ20021332A3 (tr)
DE (1) DE60012208T2 (tr)
DK (1) DK1224179T3 (tr)
DZ (1) DZ3463A1 (tr)
EA (1) EA004937B1 (tr)
EE (1) EE200200227A (tr)
ES (1) ES2222923T3 (tr)
GE (1) GEP20043222B (tr)
GT (1) GT200000180A (tr)
HK (1) HK1048472B (tr)
HR (1) HRP20020366B1 (tr)
HU (1) HUP0204009A3 (tr)
IL (1) IL148581A0 (tr)
IS (1) IS6302A (tr)
MA (1) MA26840A1 (tr)
MX (1) MXPA02004358A (tr)
NO (1) NO20021821D0 (tr)
NZ (1) NZ517738A (tr)
OA (1) OA12080A (tr)
PA (1) PA8505501A1 (tr)
PE (1) PE20010764A1 (tr)
PL (1) PL354869A1 (tr)
PT (1) PT1224179E (tr)
SI (1) SI1224179T1 (tr)
SK (1) SK5312002A3 (tr)
SV (1) SV2002000209A (tr)
TN (1) TNSN00210A1 (tr)
TR (1) TR200201167T2 (tr)
UA (1) UA72002C2 (tr)
WO (1) WO2001030759A2 (tr)
YU (1) YU31502A (tr)
ZA (1) ZA200203295B (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6441176B1 (en) 1999-10-29 2002-08-27 Pfizer Inc. Method for preparing sodium-hydrogen exchanger type 1 inhibitor
EP1355899A1 (en) * 2001-01-31 2003-10-29 Pfizer Products Inc. Ethanolates of sodium-hydrogen exchanger type-1 inhibitor
CA2472342A1 (en) * 2002-01-30 2003-08-07 Pfizer Products Inc. Zoniporide mesylate pharmaceutical compositions and processes for improving solubility of zoniporide
WO2003092694A1 (en) * 2002-05-02 2003-11-13 Pfizer Products Inc. Treatment of diabetes and diabetic complications with nhe-1 inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU46200A (sh) * 1998-02-27 2003-02-28 Pfizer Products Inc. N-(supstituisani peto-članog di-ili triaza dinezasićenog prstena)karbonil/guanidin derivati za tretiranje ishemije

Also Published As

Publication number Publication date
EP1224179B1 (en) 2004-07-14
HK1048472A1 (en) 2003-04-04
MXPA02004358A (es) 2002-11-07
EP1224179A2 (en) 2002-07-24
NZ517738A (en) 2005-06-24
WO2001030759A3 (en) 2001-09-13
HRP20020366B1 (en) 2005-04-30
SI1224179T1 (en) 2004-10-31
NO20021821L (no) 2002-04-18
MA26840A1 (fr) 2004-12-20
ZA200203295B (en) 2003-06-25
GT200000180A (es) 2002-04-11
WO2001030759A2 (en) 2001-05-03
KR100464526B1 (ko) 2005-01-03
CZ20021332A3 (cs) 2002-10-16
HUP0204009A2 (hu) 2003-03-28
ES2222923T3 (es) 2005-02-16
DE60012208D1 (de) 2004-08-19
BR0015275A (pt) 2002-07-16
UA72002C2 (en) 2005-01-17
CA2389020A1 (en) 2001-05-03
NO20021821D0 (no) 2002-04-18
CN1636991A (zh) 2005-07-13
YU31502A (sh) 2004-12-31
EA004937B1 (ru) 2004-10-28
KR20020040918A (ko) 2002-05-30
PA8505501A1 (es) 2003-09-05
AU778573B2 (en) 2004-12-09
GEP20043222B (en) 2004-04-26
DZ3463A1 (fr) 2001-05-03
DK1224179T3 (da) 2004-10-25
PE20010764A1 (es) 2001-07-23
DE60012208T2 (de) 2005-07-21
SV2002000209A (es) 2002-07-16
PT1224179E (pt) 2004-10-29
PL354869A1 (en) 2004-03-08
SK5312002A3 (en) 2003-01-09
TNSN00210A1 (fr) 2005-11-10
ATE271047T1 (de) 2004-07-15
HUP0204009A3 (en) 2004-07-28
OA12080A (en) 2003-08-25
AP2002002493A0 (en) 2002-06-30
JP2003512455A (ja) 2003-04-02
IS6302A (is) 2002-03-15
HK1048472B (zh) 2005-09-16
EA200200416A1 (ru) 2002-10-31
AR029402A1 (es) 2003-06-25
CN1384829A (zh) 2002-12-11
BG106729A (bg) 2002-12-29
IL148581A0 (en) 2002-09-12
AU7441500A (en) 2001-05-08
CO5271714A1 (es) 2003-04-30
CN1205205C (zh) 2005-06-08
HRP20020366A2 (en) 2004-02-29
EE200200227A (et) 2003-06-16

Similar Documents

Publication Publication Date Title
TR200002480T2 (tr) İzaşemi tedavisi için guanidin türevleri
NO990405L (no) Substituerte N-(indol-2-karbonyl)-glycinamider og derivater som antidiabetiske midler
TR200100605T2 (tr) Arilpiperazinler ve bunların metaloproteinaz inhibe edici maddeler (MMP) olarak kullanımı
NO20005237D0 (no) Heterocyklisk substituerte amider anvendt som calpain- inhibitorer
DK0931788T3 (da) Metalloproteasehæmmere
TR199901191T2 (tr) Benzamidoaldehitlerin sistein proteazi inhibitörü olarak kullanimi.
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
ATE269312T1 (de) N-(amidinophenyl)-n'-(subst.)-3h-2,4- benzodiazepin-3-on derivative als faktor xa inhibitoren
CA2318145A1 (en) Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
DE60121461D1 (de) Kondensierte pyridoindolderivate
BR0212925A (pt) Derivados de idol como inibidores de cox ii
NO20003828L (no) 2,3,4,5-tetrahydro-1H-[1,4]-benzodiazepin-3-hydroksamsyrer som matriks-metalloproteinase inhibitorer
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
BR9813719A (pt) Agentes terapêuticos
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
NO983444L (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
NO20023951L (no) Arylpiperaziner og arylpiperidiner og deres anvendelse som metalloproteinaseinhiberende midler
YU79602A (en) Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)
PT1292290E (pt) Composicoes farmaceuticas que compreendem derivados de acriloil-distamicina e inibidores de topoisomerase 1 e ii
AP2002002493A0 (en) Sodium-hydrogen exchanger type 1 inhibitor crystals.
BR0107204A (pt) Inibidores da angiogênese de hidrazida e alcoxiamida
BR9912374A (pt) Isoquinolinas como inibidores de urocinase
UY26417A1 (es) Cristales de inhibidor del intercambiador de sodio-hidrógeno tipo 1
MXPA04004685A (es) Procedimientos para preparar inhibidores de tipo-1 de intercambiador sodio-hidrogeno.
TH58562A (th) สารประกอบสำหรับการบำบัดรักษาการขาดโลหิตเฉพาะแห่ง